NCT04957485Phase 2Active not recruiting

Study to Assess the Safety and Immunogenicity of TPOXX® When Administered Orally for 28 Days With JYNNEOS

Study sponsor: SIGA Technologies

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2027-01-01Estimated
Enrollment · participants100Actual
Source updated2026-09-14Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Primary completion date changed

Before: 1 Jan 2026. After: 1 Jan 2027.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview